Theralase Technologies Inc. V.TLT

I am almost convinced there's been a push

[N0taP00p]

To end of of Q1 for data submission. This conference didn't move the needle much (and people think message boards do. Smh).  If delayed, I hope they get a few more 360 and 450 day data from patients with the optimized protocol. The next conference in May will hopefully bring more focus on this company.  Can't seem to shake 30 US cents. That's the bitter truth right now.  I'm hoping the next NR is NOT for raising more money.  Hope is all I got left after waiting so many years.

[ScienceFirst]

N0ta ... Markets are closed  Family Day  The Toronto Stock Exchange is closed on Monday, February 20, 2023.

[N0taP00p]

I do know that. But thanks.    The buzz from the posted data should have already made a difference starting Thu or Friday.  People plan ahead and read before they decide what to attend, what they are wowed about, what they will tell their friends about.  Obviously, it didn't make any difference. Tells me we need the right opinion makers on this plus a few more data points

[enriquesuave]

It seems more about just exactly when. Not if. Imho 

[N0taP00p]

Ah, Enrique. Wish I could buy a pound of patience at the local grocery store. I'm running thin. Will hold for another 4 months till end of Q2. If by then, we don't have this stock well above a dollar, well... 

[gebremeskel]

A good rule of thumb is to wait at least one market day after a major event before you commence whining about the market reaction to the major event. (The Basher's Manual, Section 2, subsection 3, paragraph 1 - "Don't be Too Obvious!") 

[N0taP00p]

Boo. Go away or work harder to make the stock go up on Tuesday. Yes? 

[Kayz88]

Not sure if this is of value, but based on my understanding of this: "The GU-ASCO cancer symposium will take place between February 16th to 18th, 2023 in San Francisco, California with the poster presented for general viewing and discussion within Poster Session B: Prostate Cancer and Urothelial Carcinoma on February 17, 2023 at 12:30 PM to 2:00 PM and 5:15 PM to 6:15 PM." They

[Oilminerdeluxe]

I think we need both BTD and AA before we reach +$1. Maybe just BTD will do fine, but nothing ever moves the stock, so I go for both :-)

[N0taP00p]

Oilminer: Yes on BTD and AA, maybe with some more oversight from the FDA (given the recent abuses of AA).  What I would really hope for is that the FDA  looks at the safety profile and considers an option for patients to try this before BCG. Essentially, an alternative to BCG.   Theralase could potentially develop a more frequent treatment protocol (say, quarterly for one year

[N0taP00p]

I'm happy to be proven wrong next week, Kayz88. Thanks for your thoughts. Maybe there just wasn't enough time on Friday. Next week will show us how well it was received... or not. Best. 

[ScienceFirst]

Again, and unless it's not a question about waiting for administrative documents that need to be added to the FDA application form, the most logical explanation would be that they want to include the most optimal optimized patients in such FDA application so when the FDA press releases its final decision, we have the highest possible efficacy %s hitting the news wires. The Dec. 16 press

[skys1]

ScienceFirst, NOtaPOOp is wrong, he is a POOP. He might even be FGP. Notice his first post was only 3 months ago and 3 days ago he called you Bencro. There is only one other on this board that calls you that, FGP. I think it is obvious who this guy is.

[N0taP00p]

Ooo boy, skys. I thought some of you tin-hats had put me on ignore. You can still do it. Give it a try. 

[N0taP00p]

Not sure what triggers the knee-jerk slamming of other anonymous posters every 3 posts or so. Can't we be rich (in our minds anyway) and happy? 

[consultant99]

I disagree with your assumption that the most logical explanation would be that they want to include the most optimized patients in such FGDA application. At least I hope not... The company is in constant contact with the FDA and has not waivered in their communication to shareholders that the plan was to submit data for the first 25 patients in their application for BTD. As I previously posted

[BlueFranky]

Thank you for that well articulated post, consultant.! Onward and upward

[N0taP00p]

Consultant99: Yes, you're probably right. Missed the fact about the IRs pending further investigation and CSS resources to do the analysis, which they asterisked in November. Let's hope that's the case and by now, all of that is done. In the process, maybe a few others made it to 450 days too. In any case, we're running close to the end of February quarterly report. Next two weeks

[Longholder99]

I'm guessing some Docs who are smart investors may grab some shares tomorrow. But the true commercial multi million share buys won't come until BTD and AA.  The needle.will likely move tomorrow but I'm not sure how much.  Docs have some money to invest. But not as much as Roche or Merck.  Just my opinion.  

[99942Apophis]

In my opinion anyone attending ASCO that would be interested in buying TLT stock would spend 10 to 50 hours reading Phase 1 & 2 clinical data from the beginning to now. They will look at all NRs to get a "feel" of the company, remember those that attend are looking for advancements in this field so professional curiosity will be at work. If some are blown away they may seek investing